Ahead of the IPO, shares of Glenmark Life Sciences were trading at Rs 855 per share marking a premium of Rs 135 or 18.75% at the upper price band
The public issue will have a fresh issue of equity shares worth up to Rs 1,060 crore and sale of up to 63 lakh equity shares by Glenmark Pharma
Glenmark Life Sciences IPO opens on July 27 and closes on July 29. The price band for the issue has been fixed at Rs 695-720 per share.